Fidelity Investments’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-19,945
| Closed | -$79.8K | – | 5484 |
|
|
2025
Q2 | $79.8K | Sell |
19,945
-1,158,707
| -98% | -$2.87M | ﹤0.01% | 3701 |
|
|
2025
Q1 | $1.07M | Sell |
1,178,652
-645,806
| -35% | -$895K | ﹤0.01% | 2655 |
|
|
2024
Q4 | $5.05M | Sell |
1,824,458
-654,231
| -26% | -$2.49M | ﹤0.01% | 2149 |
|
|
2024
Q3 | $13M | Buy |
2,478,689
+1,262
| +0.1% | +$6.55K | ﹤0.01% | 1844 |
|
|
2024
Q2 | $11M | Buy |
2,477,427
+509,995
| +26% | +$2.47M | ﹤0.01% | 1842 |
|
|
2024
Q1 | $15.1M | Sell |
1,967,432
-304,874
| -13% | -$1.67M | ﹤0.01% | 1753 |
|
|
2023
Q4 | $9.68M | Sell |
2,272,306
-192,926
| -8% | -$685K | ﹤0.01% | 1856 |
|
|
2023
Q3 | $10.4M | Buy |
2,465,232
+1,716,398
| +229% | +$8.73M | ﹤0.01% | 1819 |
|
|
2023
Q2 | $4.17M | Buy |
748,834
+45,838
| +7% | +$271K | ﹤0.01% | 2116 |
|
|
2023
Q1 | $4.03M | Buy |
+702,996
| New | +$1.86M | ﹤0.01% | 2156 |
|
|
2022
Q4 | – | Sell |
-609,380
| Closed | -$1.63M | – | 5476 |
|
|
2022
Q3 | $1.63M | Sell |
609,380
-439
| -0.1% | -$1.59K | ﹤0.01% | 2479 |
|
|
2022
Q2 | $2.91M | Buy |
609,819
+225
| +0% | +$978 | ﹤0.01% | 2385 |
|
|
2022
Q1 | $2.49M | Buy |
609,594
+214
| +0% | +$1.26K | ﹤0.01% | 2548 |
|
|
2021
Q4 | $4.16M | Hold |
609,380
| – | – | ﹤0.01% | 2407 |
|
|
2021
Q3 | $7.06M | Hold |
609,380
| – | – | ﹤0.01% | 2256 |
|
|
2021
Q2 | $10.4M | Hold |
609,380
| – | – | ﹤0.01% | 2094 |
|
|
2021
Q1 | $12.1M | Hold |
609,380
| – | – | ﹤0.01% | 1969 |
|
|
2020
Q4 | $12.6M | Hold |
609,380
| – | – | ﹤0.01% | 1891 |
|
|
2020
Q3 | $16M | Buy |
+609,380
| New | +$15.1M | ﹤0.01% | 1660 |
|
Fidelity Investments's INZY Position: Q3 2025 in Review
Fidelity Investments sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 19,945 shares — an estimated $79.8K sold.
Fidelity Investments first reported a position in INZY in Q3 2020 and held it in 19 quarters. The position peaked at $16M in Q3 2020. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.
- Fidelity Investments reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
- Fidelity Investments sold 19,945 Inozyme Pharma shares in Q3 2025, an estimated $79.8K.
- Fidelity Investments first reported a position in Inozyme Pharma in Q3 2020 and held it in 19 quarters.
- Fidelity Investments's Inozyme Pharma position peaked at $16M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.
Based on Fidelity Investments's 13F filing for Q3 2025, filed 13 Nov 2025.